Compare FKWL & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FKWL | SRZN |
|---|---|---|
| Founded | 1981 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Medicinal Chemicals and Botanical Products |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 53.5M | 117.8M |
| IPO Year | 1996 | N/A |
| Metric | FKWL | SRZN |
|---|---|---|
| Price | $4.24 | $21.66 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.00 | ★ $38.50 |
| AVG Volume (30 Days) | 10.7K | ★ 125.3K |
| Earning Date | 11-14-2025 | 11-07-2025 |
| Dividend Yield | ★ 0.95% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $45,508,949.00 | $3,604,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 32.05 | N/A |
| 52 Week Low | $3.67 | $5.90 |
| 52 Week High | $7.45 | $24.94 |
| Indicator | FKWL | SRZN |
|---|---|---|
| Relative Strength Index (RSI) | 36.20 | 62.47 |
| Support Level | $4.29 | $20.02 |
| Resistance Level | $4.64 | $24.94 |
| Average True Range (ATR) | 0.15 | 1.93 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 21.13 | 66.27 |
Franklin Wireless Corp is a provider of wireless solutions, including mobile hotspots, routers, and modems, as well as hardware and software products that support machine-to-machine (M2M) applications and the Internet of Things (IoT). Its M2M and IoT solutions include embedded modules, modems, and gateways built to deliver reliable always-on connectivity supporting a spectrum of applications. These products are designed to solve wireless connectivity challenges in a range of vertical markets, including video surveillance, digital signage, home security, oil and gas exploration, kiosks, fleet management, smart grid, vehicle diagnostics, and telematics.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).